HBcAg and HBeAg expression: how, where, why or why not?
- PMID: 1822517
- DOI: 10.1016/0168-8278(91)90027-9
HBcAg and HBeAg expression: how, where, why or why not?
Similar articles
-
Synthesis of hepatitis B virus e antigen in E. coli.Virus Res. 1989 Sep;14(1):27-47. doi: 10.1016/0168-1702(89)90067-1. Virus Res. 1989. PMID: 2683475
-
Molecular basis of the diversity of hepatitis B virus core-gene products.Arch Virol Suppl. 1993;8:43-52. doi: 10.1007/978-3-7091-9312-9_5. Arch Virol Suppl. 1993. PMID: 8260876 Review.
-
Hepatitis B virus core and e antigen: immune recognition and use as a vaccine carrier moiety.Intervirology. 1996;39(1-2):104-10. doi: 10.1159/000150481. Intervirology. 1996. PMID: 8957676
-
Hepatitis B virus C-gene variants.Arch Virol Suppl. 1993;8:155-69. doi: 10.1007/978-3-7091-9312-9_16. Arch Virol Suppl. 1993. PMID: 8260861 Review.
-
The secretory core protein of human hepatitis B virus is expressed on the cell surface.J Virol. 1989 Dec;63(12):5399-404. doi: 10.1128/JVI.63.12.5399-5404.1989. J Virol. 1989. PMID: 2685356 Free PMC article.
Cited by
-
MAFLD is Associated with the Risk of Liver Fibrosis and Inflammatory Activity in HBeAg-Negative CHB Patients.Diabetes Metab Syndr Obes. 2022 Mar 1;15:673-683. doi: 10.2147/DMSO.S351492. eCollection 2022. Diabetes Metab Syndr Obes. 2022. PMID: 35256849 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources